Selected research
Market Outlook & Growth Opportunities
Global Companion Animal External Medicine Market Outlook and Growth Opportunities 2026
Market perspective
The global Companion Animal External Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Companion Animal External Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Companion Animal External Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Companion Animal External Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Companion Animal External Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Companion Animal External Medicine market include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Companion Animal External Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Companion Animal External Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Companion Animal External Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animal External Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Companion Animal External Medicine Segment by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Companion Animal External Medicine Segment by Type
Injection
Unguent
Companion Animal External Medicine Segment by Application
Cats
Dogs
Other
Companion Animal External Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Companion Animal External Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Companion Animal External Medicine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Companion Animal External Medicine significant trends, drivers, influence factors in global and regions.
6. To analyze Companion Animal External Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal External Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animal External Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal External Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Companion Animal External Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animal External Medicine industry.
Chapter 3: Detailed analysis of Companion Animal External Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Companion Animal External Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Companion Animal External Medicine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Unguent
Applications
- Cats
- Dogs
- Other
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Companion Animal External Medicine Sales Value (2021-2032)
- 1.2.2 Global Companion Animal External Medicine Sales Volume (2021-2032)
- 1.2.3 Global Companion Animal External Medicine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Companion Animal External Medicine Market Dynamics
- 2.1 Companion Animal External Medicine Industry Trends
- 2.2 Companion Animal External Medicine Industry Drivers
- 2.3 Companion Animal External Medicine Industry Opportunities and Challenges
- 2.4 Companion Animal External Medicine Industry Restraints
3 Companion Animal External Medicine Market by Company
- 3.1 Global Companion Animal External Medicine Company Revenue Ranking in 2025
- 3.2 Global Companion Animal External Medicine Revenue by Company (2021-2026)
- 3.3 Global Companion Animal External Medicine Sales Volume by Company (2021-2026)
- 3.4 Global Companion Animal External Medicine Average Price by Company (2021-2026)
- 3.5 Global Companion Animal External Medicine Company Ranking (2024-2026)
- 3.6 Global Companion Animal External Medicine Company Manufacturing Base and Headquarters
- 3.7 Global Companion Animal External Medicine Company Product Type and Application
- 3.8 Global Companion Animal External Medicine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Companion Animal External Medicine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Companion Animal External Medicine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Companion Animal External Medicine Market by Type
- 4.1 Companion Animal External Medicine Type Introduction
- 4.1.1 Injection
- 4.1.2 Unguent
- 4.2 Global Companion Animal External Medicine Sales Volume by Type
- 4.2.1 Global Companion Animal External Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Companion Animal External Medicine Sales Volume by Type (2021-2032)
- 4.2.3 Global Companion Animal External Medicine Sales Volume Share by Type (2021-2032)
- 4.3 Global Companion Animal External Medicine Sales Value by Type
- 4.3.1 Global Companion Animal External Medicine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Companion Animal External Medicine Sales Value by Type (2021-2032)
- 4.3.3 Global Companion Animal External Medicine Sales Value Share by Type (2021-2032)
5 Companion Animal External Medicine Market by Application
- 5.1 Companion Animal External Medicine Application Introduction
- 5.1.1 Cats
- 5.1.2 Dogs
- 5.1.3 Other
- 5.2 Global Companion Animal External Medicine Sales Volume by Application
- 5.2.1 Global Companion Animal External Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Companion Animal External Medicine Sales Volume by Application (2021-2032)
- 5.2.3 Global Companion Animal External Medicine Sales Volume Share by Application (2021-2032)
- 5.3 Global Companion Animal External Medicine Sales Value by Application
- 5.3.1 Global Companion Animal External Medicine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Companion Animal External Medicine Sales Value by Application (2021-2032)
- 5.3.3 Global Companion Animal External Medicine Sales Value Share by Application (2021-2032)
6 Companion Animal External Medicine Regional Sales and Value Analysis
- 6.1 Global Companion Animal External Medicine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Companion Animal External Medicine Sales by Region (2021-2032)
- 6.2.1 Global Companion Animal External Medicine Sales by Region: 2021-2026
- 6.2.2 Global Companion Animal External Medicine Sales by Region (2027-2032)
- 6.3 Global Companion Animal External Medicine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Companion Animal External Medicine Sales Value by Region (2021-2032)
- 6.4.1 Global Companion Animal External Medicine Sales Value by Region: 2021-2026
- 6.4.2 Global Companion Animal External Medicine Sales Value by Region (2027-2032)
- 6.5 Global Companion Animal External Medicine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Companion Animal External Medicine Sales Value (2021-2032)
- 6.6.2 North America Companion Animal External Medicine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Companion Animal External Medicine Sales Value (2021-2032)
- 6.7.2 Europe Companion Animal External Medicine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Companion Animal External Medicine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Companion Animal External Medicine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Companion Animal External Medicine Sales Value (2021-2032)
- 6.9.2 South America Companion Animal External Medicine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Companion Animal External Medicine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Companion Animal External Medicine Sales Value Share by Country, 2025 VS 2032
7 Companion Animal External Medicine Country-level Sales and Value Analysis
- 7.1 Global Companion Animal External Medicine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Companion Animal External Medicine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Companion Animal External Medicine Sales by Country (2021-2032)
- 7.3.1 Global Companion Animal External Medicine Sales by Country (2021-2026)
- 7.3.2 Global Companion Animal External Medicine Sales by Country (2027-2032)
- 7.4 Global Companion Animal External Medicine Sales Value by Country (2021-2032)
- 7.4.1 Global Companion Animal External Medicine Sales Value by Country (2021-2026)
- 7.4.2 Global Companion Animal External Medicine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Companion Animal External Medicine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Companion Animal External Medicine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Companion Animal External Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bimeda Animal Health
- 8.1.1 Bimeda Animal Health Company Information
- 8.1.2 Bimeda Animal Health Business Overview
- 8.1.3 Bimeda Animal Health Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Bimeda Animal Health Companion Animal External Medicine Product Portfolio
- 8.1.5 Bimeda Animal Health Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Companion Animal External Medicine Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Ceva Sante Animale
- 8.3.1 Ceva Sante Animale Company Information
- 8.3.2 Ceva Sante Animale Business Overview
- 8.3.3 Ceva Sante Animale Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Ceva Sante Animale Companion Animal External Medicine Product Portfolio
- 8.3.5 Ceva Sante Animale Recent Developments
- 8.4 Chanelle
- 8.4.1 Chanelle Company Information
- 8.4.2 Chanelle Business Overview
- 8.4.3 Chanelle Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Chanelle Companion Animal External Medicine Product Portfolio
- 8.4.5 Chanelle Recent Developments
- 8.5 Elanco
- 8.5.1 Elanco Company Information
- 8.5.2 Elanco Business Overview
- 8.5.3 Elanco Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Elanco Companion Animal External Medicine Product Portfolio
- 8.5.5 Elanco Recent Developments
- 8.6 Vetoquinol
- 8.6.1 Vetoquinol Company Information
- 8.6.2 Vetoquinol Business Overview
- 8.6.3 Vetoquinol Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Vetoquinol Companion Animal External Medicine Product Portfolio
- 8.6.5 Vetoquinol Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Virbac Companion Animal External Medicine Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Bayer Companion Animal External Medicine Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 Merck
- 8.9.1 Merck Company Information
- 8.9.2 Merck Business Overview
- 8.9.3 Merck Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Merck Companion Animal External Medicine Product Portfolio
- 8.9.5 Merck Recent Developments
- 8.10 Zoetis
- 8.10.1 Zoetis Company Information
- 8.10.2 Zoetis Business Overview
- 8.10.3 Zoetis Companion Animal External Medicine Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Zoetis Companion Animal External Medicine Product Portfolio
- 8.10.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Companion Animal External Medicine Value Chain Analysis
- 9.1.1 Companion Animal External Medicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Companion Animal External Medicine Sales Mode & Process
- 9.2 Companion Animal External Medicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Companion Animal External Medicine Distributors
- 9.2.3 Companion Animal External Medicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst